TPR vs. SMMT
TPR (Tapestry, Inc.) and SMMT (Summit Therapeutics Inc.) are both stocks. TPR operates in Luxury Goods (Consumer Cyclical), while SMMT operates in Biotechnology (Healthcare). Over the past 10 years, TPR returned 17.11%/yr vs 4.15%/yr for SMMT. At a 0.16 correlation, their price movements are largely independent.
Performance
TPR vs. SMMT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TPR achieves a 10.89% return, which is significantly higher than SMMT's -19.33% return. Over the past 10 years, TPR has outperformed SMMT with an annualized return of 17.11%, while SMMT has yielded a comparatively lower 4.15% annualized return.
TPR
- 1D
- 0.57%
- 1M
- 5.86%
- YTD
- 10.89%
- 6M
- 20.82%
- 1Y
- 80.77%
- 3Y*
- 52.54%
- 5Y*
- 29.87%
- 10Y*
- 17.11%
SMMT
- 1D
- -4.47%
- 1M
- -21.96%
- YTD
- -19.33%
- 6M
- -24.24%
- 1Y
- -31.47%
- 3Y*
- 100.52%
- 5Y*
- 13.84%
- 10Y*
- 4.15%
TPR vs. SMMT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TPR Tapestry, Inc. | 10.89% | 98.73% | 82.80% | 0.16% | -3.32% | 32.29% | 16.86% | -15.97% | -22.09% | 30.48% |
SMMT Summit Therapeutics Inc. | -19.33% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
Correlation
The correlation between TPR and SMMT is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2015 | 0.16 |
Fundamentals
TPR:
$29.35B
SMMT:
$10.94B
TPR:
$3.15
SMMT:
-$1.60
TPR:
43.01
SMMT:
20.04
TPR:
$7.85B
SMMT:
$0.00
TPR:
$5.98B
SMMT:
-$83.36K
TPR:
$1.06B
SMMT:
-$738.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TPR vs. SMMT — Risk / Return Rank
TPR
SMMT
TPR vs. SMMT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Tapestry, Inc. (TPR) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TPR | SMMT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.41 | ||
| Sortino ratioReturn per unit of downside risk | +2.47 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 0.98 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 4.23 | -0.60 | +4.83 |
| Martin ratioReturn relative to average drawdown | 10.73 | -0.92 | +11.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TPR | SMMT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.99 | -0.42 | +2.41 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.75 | 0.08 | +0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | 0.03 | +0.36 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.44 | 0.02 | +0.42 |
Drawdowns
TPR vs. SMMT - Drawdown Comparison
The maximum TPR drawdown since its inception was -82.55%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for TPR and SMMT.
Loading charts...
Drawdown Indicators
| TPR | SMMT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.55% | -95.75% | +13.20% |
Max Drawdown (1Y)Largest decline over 1 year | -19.21% | -52.76% | +33.55% |
Max Drawdown (3Y)Largest decline over 3 years | -39.54% | -62.26% | +22.72% |
Max Drawdown (5Y)Largest decline over 5 years | -41.87% | -91.78% | +49.91% |
Max Drawdown (10Y)Largest decline over 10 years | -79.06% | -95.75% | +16.69% |
Current DrawdownCurrent decline from peak | -11.72% | -61.55% | +49.83% |
Average DrawdownAverage peak-to-trough decline | -27.74% | -57.64% | +29.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.55% | 34.32% | -26.77% |
Volatility
TPR vs. SMMT - Volatility Comparison
The current volatility for Tapestry, Inc. (TPR) is 8.83%, while Summit Therapeutics Inc. (SMMT) has a volatility of 22.47%. This indicates that TPR experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TPR | SMMT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.83% | 22.47% | -13.64% |
Volatility (6M)Calculated over the trailing 6-month period | 27.95% | 56.53% | -28.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.87% | 75.95% | -35.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 40.24% | 185.12% | -144.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.23% | 144.63% | -100.40% |
Dividends
TPR vs. SMMT - Dividend Comparison
TPR's dividend yield for the trailing twelve months is around 1.14%, while SMMT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TPR Tapestry, Inc. | 1.14% | 1.17% | 2.14% | 3.53% | 2.89% | 1.23% | 1.09% | 5.01% | 3.00% | 3.06% | 3.85% | 4.13% |
Financials
TPR vs. SMMT - Financials Comparison
This section allows you to compare key financial metrics between Tapestry, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TPR and SMMT have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (22.47%) compared to TPR (8.83%). In terms of maximum drawdown, TPR dropped -82.55% vs SMMT's -95.75%.
TPR currently has the higher Sharpe Ratio (1.99 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TPR and SMMT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer